Curated News
By: NewsRamp Editorial Staff
August 25, 2026
Nanox Imaging Reports Revenue Growth and Expands AI-Powered Imaging Platform
TLDR
- Nanox's revenue grew 54% to $4.3M, with FDA-cleared AI and partnerships with major hospitals, positioning it for market advantage.
- Nanox integrates imaging hardware, FDA-cleared AI, cloud software, teleradiology, and health IT into an end-to-end platform for streamlined diagnostics.
- Nanox expands access to preventive healthcare through affordable imaging and AI, enabling earlier detection and improved clinical efficiency for all.
- Nanox combines imaging hardware with AI and teleradiology, securing FDA clearances and collaborating with top institutions like RadNet and Cedars-Sinai.
Impact - Why it Matters
This news matters because Nanox's integrated platform has the potential to revolutionize preventive healthcare by making advanced imaging more affordable and accessible. With FDA-cleared AI solutions and collaborations with major health systems, Nanox is positioned to improve early detection and clinical outcomes, which could reduce healthcare costs and save lives. Investors and healthcare providers should watch Nanox as it continues to grow and innovate in the medical imaging space.
Summary
Nanox Imaging (NASDAQ: NNOX) is advancing its mission to transform healthcare through preventive medicine by integrating an end-to-end platform that combines proprietary imaging hardware, FDA-cleared AI applications, cloud software, radiology services, and healthcare IT. The company's commercial reach is expanding through U.S. activities and collaborations with prominent healthcare organizations. In the first quarter of 2026, Nanox reported revenue of $4.3 million, up from $2.8 million in the same period last year, driven by contributions from teleradiology, imaging systems, OEM services, AI, software, and Health IT.
Nanox has secured FDA clearance for its Nanox.ARC and Nanox.ARC X systems, along with three Nanox.AI medical imaging solutions. Its commercial and clinical activities involve leading institutions such as RadNet, Cedars-Sinai, Corewell Health, and Brigham and Women’s Hospital. The company's platform is designed to enable earlier detection, improve clinical efficiency, and broaden access to medical imaging, positioning it as a key player in the shift toward preventive healthcare.
As part of its growth strategy, Nanox is leveraging its integrated offerings to address the need for affordable and accessible imaging solutions. The company's recent revenue growth reflects increasing adoption of its technologies. For more details, visit the Nanox (NASDAQ: NNOX) newsroom. The latest updates are also available at https://ibn.fm/NNOX. This news is brought to you by AINewsWire, a platform focused on AI advancements, and is part of the Dynamic Brand Portfolio @ IBN, which provides comprehensive corporate communications solutions.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, Nanox Imaging Reports Revenue Growth and Expands AI-Powered Imaging Platform
